Please turn JavaScript on
header-image

Biotech Investments

Receive updates from Biotech Investments for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Biotech Investments. Unsubscribe at any time.

Site title: Biotech Investments – Independent Medical Rating Agency for Biotech and Pharmaceutical Assets. Purpose-built for Investors and Industry Partners.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  4.76 / day

Message History

Galimedix, Inc.

/ Key word(s): Conference

Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PD 2026 Conference

05.03.2026 / 14:00 CET/CEST

The issuer is solely responsible for the content of this announcement.

Galimedix Therapeutics to present pr...


Read full story

Cellbox Solutions GmbH

/ Key word(s): Financing/Personnel

Cellbox Solutions closes first tranche of Series A financing and appoints new CBO/CFO to accelerate international growth

05.03.2026 / 10:00 CET/CEST

The issuer is solely responsible for the content of this announcement.

Cellbox Solutions closes first tranche of Serie...


Read full story

Basel, Switzerland. March 5, 2026, 7am CET.

 

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multidrug-resistant (MDR) ...


Read full story